The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer’s Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement
Journal of Alzheimer's Disease · 2023
DOI: 10.3233/jad-230659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von John E Lewis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. Hauptthemen laut MEDLINE: Aloe, Alzheimer Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is a leading killer of Americans, imparting a tremendous societal toll. Relationships between immune function and inflammation with cognition are well-established in AD, but the Th1/Th2 ratio of immune function is unknown. Describing the Th1/Th2 ratio and its relationship with cognition may shed light on the disease’s clinical context. How the Th1/Th2 ratio responds to dietary supplementation is another unknown question in this population.
Objective
The objectives of the study were to: 1) characterize the Th1/Th2 ratio according to IL-2/IL-10, IFN-γ/IL-10, IL-2/IL-4, IFN-γ/IL-4, IL-2/TNF-α, and IFN-γ/TNF-α in subjects with moderate-to-severe AD and in comparison to healthy adults; 2) investigate the effect of an aloe polymannose multinutrient complex (APMC) dietary supplement on the Th1/Th2 ratios over 12 months; and 3) compare the changes in the Th1/Th2 ratios with the changes in cognition from baseline to 12 months.
Methods
Subjects consumed 2.5 g of the APMC four times per day for 12 months, and they were assessed on cognition and cytokines at baseline and 12 months.
Results
The Th1/Th2 ratios in AD patients were significantly higher than the healthy controls, and five of the six ratios decreased from baseline to 12 months follow-up (other than IL-2/TNF-α). Several significant relationships were noted between the changes in Th1/Th2 ratios with cognitive assessments.
Conclusions
Our results showed an overall rebalancing of the Th1/Th2 ratio in response to APMC, these changes were related to improved cognition in subjects with moderate-to-severe AD, and the APMC supplement was safely tolerated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
- Wellness Quest, LLC, Grand Prairie, TX, USA.
- Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
- Department of Family and Community Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Zitieren
APA
Lewis, J. E., Reginald McDaniel, H., Woolger, J. M., & Khan, S. A. (2023). The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer’s Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-230659
Vancouver
Lewis JE, Reginald McDaniel H, Woolger JM, Khan SA. The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer’s Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-230659
BibTeX
@article{Lewis2023,
author = {Lewis, John E and Reginald McDaniel, H and Woolger, Judi M and Khan, Sher Ali},
title = {The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer’s Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement},
journal = {Journal of Alzheimer's Disease},
year = {2023},
doi = {10.3233/jad-230659}
}
EUVIMED